Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation
2012 ◽
Vol 89
(3)
◽
pp. 220-227
◽
2019 ◽
Vol 28
(22)
◽
pp. 1473-1479
◽
2016 ◽
pp. 3-20
◽
2016 ◽
pp. 836-840